Medical/Pharmaceuticals
Nanoform signs GMP manufacturing program with TargTex following formulation success
HELSINKI, Feb. 4, 2022 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, today announced it has signed a GMP1 manufacturing program (clinical development) to enhance TargTex's Glioblastoma multiforme drug candidate. The program starts with a PoP (Proof of Process) ph...
2022-02-04 15:54
3045
NCCN Joins the Call to 'Close the Care Gap' on World Cancer Day
Global nonprofit National Comprehensive Cancer Network participates in annual awareness day, highlighting cancer care disparities and free resources to help, detailed at NCCN.org/wcd. PLYMOUTH MEETING, Pa., Feb. 4, 2022 /PRNewswire/ -- World Cancer Day is observed everyFebruary 4. This year, the...
2022-02-04 13:37
2381
Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain*
* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted)▼ is the first protein-based COVID-19 vaccine authorized inGreat Britain * Novavax and the U.K. Vaccines Taskforce previously announced an agreement for up to 60 million doses * Authorization based on data including an ongoing pivotal Ph...
2022-02-03 21:22
2983
Mentice publishes the company's year-end report for the period January-December 2021
STOCKHOLM, Feb. 3, 2022 /PRNewswire/ -- Continued strength with net sales growth above 30% despite the pandemic Fourth quarter (October-December 2021) * Order intake amounted to 73.7 (73.1) MSEK. * Net sales amounted to 67.7 (45.9) MSEK. * Operating income for the period before depreciation...
2022-02-03 15:37
1984
Phenomenex Celebrates 40-Years of Keeping Scientists Happy & What's to Come
TORRANCE, Calif., Feb. 3, 2022 /PRNewswire/ -- Phenomenex, a global life sciences company that offers analytical chemistry solutions for separation and purification, proudly marks its40th anniversary in 2022 with a new mission statement and several exciting strategic initiatives that will deliver...
2022-02-03 06:49
2424
Zeus Launches PTFE Sub-Lite-Wall® Multi-Lumen Tubing for Steerable Catheters
New Multi-Lumen Tubing Helps Simplify Steerable Catheter Construction, Reduce Manufacturing Steps, and Improve Yields ORANGEBURG, S.C., Feb. 2, 2022 /PRNewswire/ -- Zeus, the global leader in advanced polymer solutions, announced today that it has added PTFE Sub-Lite-Wall ® multi-lumen tubing to ...
2022-02-02 21:00
1849
Avidien Technologies Receives $4M Investment from BroadOak Capital Partners
BOSTON, Feb. 2, 2022 /PRNewswire/ -- Avidien announced today a new financing round of$4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. Avidien CEO and Founder Rich Co...
2022-02-02 18:49
2108
Elekta increases customer focus with direct presence in Philippines
STOCKHOLM, Feb. 2, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established an office inthe Philippines' capital, Manila, to offer new and existing customers superior service, education and training opportunities and faster access to the latest cancer care solutions. A dire...
2022-02-02 15:48
2214
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma
LUXEMBOURG, Feb. 2, 2022 /PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and associated Packaging services, announced today the completion of the acquisition of three manufacturing facilities...
2022-02-02 11:00
2482
World's most trusted source for chemistry information, CAS, launches major biology expansion
CAS SciFinder Discovery Platform™ redefines its role in drug discovery with the inclusion of unique biosequence data collection and capabilities COLUMBUS, Ohio, Feb. 2, 2022 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific information solutions, announce...
2022-02-02 10:42
2470
yoboo rewards customers with even greater savings in the 2.2 Free Shipping Sale
MANILA, Philippines, Feb. 2, 2022 /PRNewswire/ -- The "2.2 Free Shipping Sale" has just begun. From late January toFebruary 23, babies and moms can be surprised at the yoboo store through a variety of activities such as Follow & Win, Share & Win, Cashback, discounts, and platform coupons. The eve...
2022-02-02 04:51
2228
LANDMARK REDUCE LAP-HF II TRIAL DEMONSTRATES CLINICAL BENEFIT OF CORVIA® ATRIAL SHUNT IN LARGE SEGMENT OF HEART FAILURE PATIENTS
REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 2, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II randomized cli...
2022-02-02 01:28
1928
AMR Action Fund Appoints Scientific Advisory Board
Members will play a vital role in evaluating potential investments into clinical-stage companies developing urgently needed antibiotics BOSTON, Feb. 1, 2022 /PRNewswire/ -- The AMR Action Fund, the world's largest public-private partnership investing in the development of new antibiotics, today ...
2022-02-01 19:00
2455
Cytiva fuels biotech development in Australia and New Zealand
* VivaZome Therapeutics wins top prize with its potential to provide off-the-shelf regenerative medicines. * Part of Cytiva's BioChallenge global series, the inaugural challenge for the Australia and New Zealand region received 32 applications from various universities and companies. SYDNEY, F...
2022-02-01 07:00
2777
DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
LAUSANNE, Switzerland and DURBAN, South Africa, Feb. 1, 2022 /PRNewswire/ --
Debiopharm (www.debiopharm.com
2022-02-01 06:00
2987
Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)
SAN DIEGO, Feb. 1, 2022 /PRNewswire/ -- Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the FDA has authorized the company's investigational new drug (IND) application of DB104 (liafensine) for treatment-r...
2022-02-01 05:30
2185
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Feb. 1, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vac...
2022-02-01 04:06
2996
Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany
STOCKHOLM, Jan. 31, 2022 /PRNewswire/ -- The Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics and world leading pharmaceutical company Pfizer have joined forces to provide evidence based, clinically validated and personalized digital therapies to patients. Together, the compa...
2022-01-31 18:00
2113
Application deadline extended for Aster Guardians Global Nursing Award worth US $250,000 to 15th Feb
* Till date more than 17300+ registrations have been received from nurses from 175 countries * The announcement comes as a response to increasing requests from nurses worldwide for more time to complete the documentation process, following the Covid-19 surge * Nurses from around the world c...
2022-01-31 15:14
2487
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 29, 2022 /PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the two compan...
2022-01-29 05:28
3834
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9189
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7765
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
4738
